Ahmad H. Alhowail

Buraydah, Saudi Arabia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 87 publications

Efflux pump overexpression in fluoroquinolone multidrug resistance: molecular mechanisms, PK/PD implications, global epidemiology, and translational strategies.

Efflux pump overexpression in fluoroquinolone multidrug resistance: molecular mechanisms, PK/PD implications, global epidemiology, and translational strategies.

Journal: Frontiers in pharmacology

Published: June 02, 2026

Dapagliflozin and cognitive impairment: pharmacological mechanisms, translational evidence, and future directions.

Dapagliflozin and cognitive impairment: pharmacological mechanisms, translational evidence, and future directions.

Journal: Frontiers in pharmacology

Published: May 30, 2026

Semaglutide in cognitive dysfunction: neuroprotective potential, clinical trial limitations, and a prevention-focused framework.

Semaglutide in cognitive dysfunction: neuroprotective potential, clinical trial limitations, and a prevention-focused framework.

Journal: Frontiers in aging neuroscience

Published: April 09, 2026

Role of CXCL16/ADAM10 signaling in methotrexate-induced nephrotoxicity and its modulation by simvastatin.

Role of CXCL16/ADAM10 signaling in methotrexate-induced nephrotoxicity and its modulation by simvastatin.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: March 22, 2026

Sacubitril/Valsartan Fails to Ameliorate Cisplatin-Induced Cognitive Impairment.

Sacubitril/Valsartan Fails to Ameliorate Cisplatin-Induced Cognitive Impairment.

Journal: Drug design, development and therapy

Published: February 13, 2026

Short-term effects of alcohol detoxification on cardiovascular, hematological, and oxidative stress biomarkers: A prospective cohort study.

Short-term effects of alcohol detoxification on cardiovascular, hematological, and oxidative stress biomarkers: A prospective cohort study.

Journal: PloS one

Published: January 21, 2026

Downregulation of CXCL16/ADAM10 axis by Simvastatin attenuates tacrolimus-induced tubulointerstitial fibrosis.

Downregulation of CXCL16/ADAM10 axis by Simvastatin attenuates tacrolimus-induced tubulointerstitial fibrosis.

Journal: Scientific reports

Published: January 12, 2026

Breaking a mitochondrial danger-STING feed-forward amplifier preserves alveolar-capillary architecture and dampens interferon-chemokine signaling in acute lung injury.

Breaking a mitochondrial danger-STING feed-forward amplifier preserves alveolar-capillary architecture and dampens interferon-chemokine signaling in acute lung injury.

Journal: Tissue & cell

Published: January 03, 2026

The lack of efficacy of tirzepatide in mitigating cisplatin-induced neurotoxicity and cognitive impairment in rats.

The lack of efficacy of tirzepatide in mitigating cisplatin-induced neurotoxicity and cognitive impairment in rats.

Journal: Frontiers in toxicology

Published: November 24, 2025

Reprogramming lysosomal-purinergic crosstalk governs the synergistic attenuation of NLRP3 inflammasome activation by cyclodextrin-P2X7 blockade in diabetic rats.

Reprogramming lysosomal-purinergic crosstalk governs the synergistic attenuation of NLRP3 inflammasome activation by cyclodextrin-P2X7 blockade in diabetic rats.

Journal: European journal of pharmacology

Published: November 16, 2025

Sacubitril/valsartan mitigates cisplatin-induced liver injury through modulation of oxidative stress, Caspase-3 activity, and RXR-α signaling in experimental rats.

Sacubitril/valsartan mitigates cisplatin-induced liver injury through modulation of oxidative stress, Caspase-3 activity, and RXR-α signaling in experimental rats.

Journal: Frontiers in pharmacology

Published: November 12, 2025

Paclitaxel-induced cognitive impairment: mechanistic insights.

Paclitaxel-induced cognitive impairment: mechanistic insights.

Journal: Frontiers in pharmacology

Published: August 12, 2025

Showing 1-12 of 87

Last Updated: 09/26/2026